Supply Of 1) VACCUTAINER NEEDLE WITH VISIBILITY OF BLOOD ENTRY 22G, 2) VACCUTAINER PLASTIC ? SODIUM CITRATE 3.2% (2.7 ML) TUBE, 3) VACCUTAINER PLASTIC SODIUM FLUORIDE EDTA 2ML, 4) VACCUTAINER PLASTIC ? PLAIN WITH CLOT ACTIVATOR (4 ML) TUBE & 5) VACUT

Sharing tender

Supply Of 1) vaccutainer needle with visibility of blood entry 22g, 2) vaccutainer plastic ? sodium citrate 3.2% (2.7 ml) tube, 3) vaccutainer plastic sodium fluoride edta 2ml, 4) vaccutainer plastic ? plain with clot activator (4 ml) tube & 5) vacutainer needle with visibility of blood entry 21g for multi-s le collection , srphc82659350-vaccutainer needle with visibility of blood entry 22g [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82659360-vaccutainer plastic sodium fluoride edta 2ml [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82659370-vaccutainer plastic ? plain with clot activator (4 ml) tube shou ld have the following features- 1. made of medical grade polyethylene terephthalate (pet ), latex-free, transparent, and vacuum-sealed. 2. volume: 4.0ml plus or minus 10%. 3. additi ve: clot activator (silica particles or equivalent) evenly coated on inner wall for rapid c lotting. 4. closure made of latex free cap, color-coded with red as per international stan dard. 5. should ensure complete clot formation within 10?15 minutes. 6. label: pre-printed with additive type, lot number, expiry and fill line. 7. sterile, pyrogen-free, and non-toxic. 8. shelf life minimum of 18 months. 9. should be bis/eu-ce/usfda/iso 6710 compliant. [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82659355-vaccutainer plastic ? sodium citrate 3.2% (2.7 ml) tube should h ave the following features- 1. made of medical grade polyethylene terephthalate (pet), la tex-free, transparent, and vacuum-sealed. 2. volume: 2.7 anticoagulant volume ratio 1 par t 3.2% sodium citrate to 9 parts blood. 3. additive: trisodium citrate 3.2%, pre-dosed accur ately. 4. closure made of latex free cap, color-coded with light blue as per international standard. 5. should ensure optimal fill to maintain correct blood to additive ration. 6. la bel: pre-printed with additive type, lot number, expiry and fill line. 7. sterile, pyrogen-free, and non-toxic. 8. shelf life minimum of 18 months. 9. should be bis/eu-ce/usfda/iso 6710 com pliant. 10. batch-wise sterility/pyrogenicity/toxicity certificate shall be furnished along w ith samples and supplies. 11. environmental safety data demonstrating non-toxic combusti on and safe incineration shall be provided. 12. the firm shall provide regular training to l aboratory technicians and nursing staff to ensure proper use and performance documen tation of the supplied products. 13. the bidder shall submit two performance certificates from three different customers to whom similar products have been supplied in the last t hree years. [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] , srphc82659375-vacutainer needle with visibility of blood entry 21g for multi-s ample collection should have the following specifications: 1). the designing of the needle s should be such that it can able to minimize the pre- analytical variability throughout th e specimen collection and handling process to ensure reliable results and should be suit able for faster procedures. 2). the needles should be suitable for closed- system blood c ollection i.e drawing blood directly from the vein into vacuum collection tubes to prevent exposure of atmosphere. 3). the needles should be suitable for multi- sample coll ection.4). needles should be sterile, double-ended with a sleeve covered safety valve for use with vacutainer tube holder and vacuum blood collection tubes. 5). size of the needle should be 21g x 1 inch (gauge: 21g, length: 1 inch./25 mm).6) needle design should provide i nstant confirmation of needle placement, through visual flashback indication.7). there s hould be a chamber or similar arrangement at the needle junction for easy visual confirm ation of blood flow entry.8). needle should have low-angle bevel design and should be c oated with silicone/ similar low friction lubricant coating to ensure gentle and smooth v ein entry (for smooth painless pricking to the patients 9). the firm should provide certificate of compliance report for every batch and material used for making the needle and sterilization of the needle should comply with iso standards.10). the product should be bis/iso/ce/us fda certified and should produce the certificate while quoting in the tend er.11). the firm should supply suitable needle holders along with the needle supply and al so should submit adequate sampling material for checking suitability & for validation, verification of product [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]